Auryxia
Tetraferric tricitrate decahydrate is an iron containing phosphate binder used to treat hyperphosphatemia and iron deficiency anemia in adults with chronic kidney disease.  Tetraferric tricitrate decahydrate was granted FDA approval on 5 September 2014.